May 6, 2021 4:15 pm EDT iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
Feb 16, 2021 4:05 pm EST iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update
Feb 9, 2021 4:30 pm EST iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021